Late tumor pseudoprogression followed by complete remission after lung stereotactic ablative radiotherapy

Radiation Oncology

Volumn 8, Issue 1, 2013, Pages

  Stauder, Michael C ^a   Rooney, Jessica W ^b   Neben Wittich, Michelle A ^b   Garces, Yolanda I ^b   Olivier, Kenneth R ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Fluorodeoxyglucose F18; Radiotherapy; Stereotactic body radiotherapy; Thoracic neoplasms

Indexed keywords

FLUORODEOXYGLUCOSE F 18; OXYGEN;

AGED; AORTA STENOSIS; ARTICLE; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SIZE; CANCER STAGING; CASE REPORT; COMORBIDITY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONE BEAM COMPUTED TOMOGRAPHY; CONSULTATION; CORONARY ARTERY BYPASS GRAFT; FOLLOW UP; HEART INFARCTION; HUMAN; IMMOBILIZATION; LUNG BIOPSY; LUNG CARCINOMA; LUNG EMPHYSEMA; LUNG FUNCTION; MALE; MEDICAL HISTORY; NASAL CANNULA; PERIPHERAL VASCULAR DISEASE; POSITRON EMISSION TOMOGRAPHY; SMOKING; STEREOTACTIC ABLATIVE RADIOTHERAPY; THORAX RADIOGRAPHY; TRACHEOBRONCHIAL TOILET; TRANSBRONCHIAL BIOPSY; TREATMENT FAILURE; TREATMENT PLANNING;

AGED; AORTIC VALVE STENOSIS; COMORBIDITY; CORONARY ARTERY BYPASS; DISEASE PROGRESSION; EMPHYSEMA; HEART DISEASES; HUMANS; LUNG DISEASES; LUNG NEOPLASMS; MALE; MYOCARDIAL INFARCTION; PERIPHERAL VASCULAR DISEASES; RADIOSURGERY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; REMISSION INDUCTION;

EID: 84879814280     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-8-167     Document Type: Article

References (18)

1. Matsuo Y, Nagata Y, Mizowaki T, Takayama K, Sakamoto T, Sakamoto M, Norihisa Y, Hiraoka M. Evaluation of mass-like consolidation after stereotactic body radiation therapy for lung tumors. Int J Clin Oncol 2007, 12(5):356-362. 10.1007/s10147-007-0691-9, 17929117.
2. Takeda A, Kunieda E, Takeda T, Tanaka M, Sanuki N, Fujii H, Shigematsu N, Kubo A. Possible Misinterpretation of Demarcated Solid Patterns of Radiation Fibrosis on CT Scans as Tumor Recurrence in Patients Receiving Hypofractionated Stereotactic Radiotherapy for Lung Cancer. Int J Radiat Oncol Biol Phys 2008, 70(4):1057-1065. 10.1016/j.ijrobp.2007.07.2383, 17905527.
3. Zhang X, Liu H, Balter P, Allen PK, Komaki R, Pan T, Chuang HH, Chang JY. Positron Emission Tomography for Assessing Local Failure After Stereotactic Body Radiotherapy for Non-Small-Cell Lung Cancer. Int J Radiat Oncol Biol Phys 2012, 83(5):1558-1565. 10.1016/j.ijrobp.2011.10.035, 3474601, 22572078.
4. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer 2009, 45(2):228-247. 10.1016/j.ejca.2008.10.026, 19097774.
5. Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors. J Nucl Med 2009, 50(Suppl 1):122S-150S. 2755245, 19403881.
6. Young H, Baum R, Cremerius U, Herholz K, Hoekstra O, Lammertsma AA, Pruim J, Price P. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. Eur J Cancer 1999, 35(13):1773-1782. 10.1016/S0959-8049(99)00229-4, 10673991.
7. Stauder MC, Macdonald OK, Olivier KR, Call JA, Lafata K, Mayo CS, Miller RC, Brown PD, Bauer HJ, Garces YI. Early pulmonary toxicity following lung stereotactic body radiation therapy delivered in consecutive daily fractions. Radiother Oncol 2011, 99(2):166-171. 10.1016/j.radonc.2011.04.002, 21571384.
8. Benedict SH, Yenice KM, Followill D, Galvin JM, Hinson W, Kavanagh B, Keall P, Lovelock M, Meeks S, Papiez L, et al. Stereotactic body radiation therapy: the report of AAPM Task Group 101. Medical physics 2010, 37(8):4078-4101. 10.1118/1.3438081, 20879569.
9. Baumann P, Nyman J, Hoyer M, Wennberg B, Gagliardi G, Lax I, Drugge N, Ekberg L, Friesland S, Johansson K-A, et al. Outcome in a Prospective Phase II Trial of Medically Inoperable Stage I Non-Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiotherapy. J Clin Oncol 2009, 27(20):3290-3296. 10.1200/JCO.2008.21.5681, 19414667.
10. Fakiris AJ, McGarry RC, Yiannoutsos CT, Papiez L, Williams M, Henderson MA, Timmerman R. Stereotactic Body Radiation Therapy for Early-Stage Non-Small-Cell Lung Carcinoma: Four-Year Results of a Prospective Phase II Study. Int J Radiat Oncol Biol Phys 2009, 75(3):677-682. 10.1016/j.ijrobp.2008.11.042, 19251380.
11. McGarry RC, Papiez L, Williams M, Whitford T, Timmerman RD. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: Phase I study. Int J Radiat Oncol Biol Phys 2005, 63(4):1010-1015. 10.1016/j.ijrobp.2005.03.073, 16115740.
12. Nagata Y, Takayama K, Matsuo Y, Norihisa Y, Mizowaki T, Sakamoto T, Sakamoto M, Mitsumori M, Shibuya K, Araki N, et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2005, 63(5):1427-1431. 10.1016/j.ijrobp.2005.05.034, 16169670.
13. Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, Fakiris A, Bezjak A, Videtic G, Johnstone D, et al. Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer. JAMA-J Am Med Assoc 2010, 303(11):1070-1076.
14. Radiation Therapy Oncology Group Lung Cancer Protocols. 0813 Phase I/II SBRT http://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?action=openFile&FileID=9067 Accessed July 8, 2013, Radiation Therapy Oncology Group.
15. Henderson MA, Hoopes DJ, Fletcher JW, Lin P-F, Tann M, Yiannoutsos CT, Williams MD, Fakiris AJ, McGarry RC, Timmerman RD. A Pilot Trial of Serial 18F-Fluorodeoxyglucose Positron Emission Tomography in Patients With Medically Inoperable Stage I Non-Small-Cell Lung Cancer Treated With Hypofractionated Stereotactic Body Radiotherapy. Int J Radiat Oncol Biol Phys 2010, 76(3):789-795. 10.1016/j.ijrobp.2009.02.051, 2823932, 19473777.
16. Dunlap NE, Yang W, McIntosh A, Sheng K, Benedict SH, Read PW, Larner JM. Computed tomography-based anatomic assessment overestimates local tumor recurrence in patients with mass-like consolidation after stereotactic body radiotherapy for early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2012, 84(5):1071-1077. 10.1016/j.ijrobp.2012.01.088, 22898383.
17. Allibhai Z, Cho BCJ, Taremi M, Atallah S, Hope A, Hwang D, Keshavjee S, Tsao M, Yasufuku K, Kim S-W, et al. Surgical salvage following stereotactic body radiotherapy for early-stage NSCLC. Eur Respir J 2012, 39(4):1039-1042. 10.1183/09031936.00075811, 22467727.
18. Huang K, Dahele M, Senan S, Guckenberger M, Rodrigues GB, Ward A, Boldt RG, Palma DA. Radiographic changes after lung stereotactic ablative radiotherapy (SABR) - Can we distinguish recurrence from fibrosis? A systematic review of the literature. Radiother Oncol 2012, 102(3):335-342. 10.1016/j.radonc.2011.12.018, 22305958.